Eastgate Biotech Corp.
ETBI · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Revenue | $100 | $136 | $157 | $0 |
| % Growth | -26.7% | -13.5% | – | – |
| Cost of Goods Sold | $210 | $205 | $160 | $0 |
| Gross Profit | -$110 | -$69 | -$3 | $0 |
| % Margin | -110.4% | -50.6% | -1.9% | – |
| R&D Expenses | $9 | $24 | $258 | $502 |
| G&A Expenses | $0 | $0 | $0 | $1,860 |
| SG&A Expenses | $3,155 | $1,254 | $3,170 | $2,132 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $272 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,164 | $1,278 | $3,428 | $2,634 |
| Operating Income | -$3,274 | -$1,346 | -$3,431 | -$2,634 |
| % Margin | -3,282.4% | -989.1% | -2,180.3% | – |
| Other Income/Exp. Net | -$271 | -$151 | -$288 | -$344 |
| Pre-Tax Income | -$3,544 | -$1,498 | -$3,719 | -$2,977 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,544 | -$1,498 | -$3,719 | -$2,977 |
| % Margin | -3,553.7% | -1,100.3% | -2,363.4% | – |
| EPS | -0.002 | -0.001 | 0 | -0.01 |
| % Growth | -58.3% | – | 100% | – |
| EPS Diluted | -0.002 | -0.001 | 0 | -0.01 |
| Weighted Avg Shares Out | 1,904,872 | 1,274,108 | 0 | 304,796 |
| Weighted Avg Shares Out Dil | 1,904,872 | 1,274,108 | 0 | 304,796 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $271 | $151 | $318 | $160 |
| Depreciation & Amortization | $175 | $112 | $73 | $54 |
| EBITDA | -$3,099 | -$1,235 | -$3,329 | -$2,579 |
| % Margin | -3,107.2% | -907.2% | -2,115% | – |